Innoviva, Inc. - Mar 31, 2022 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)

Role
Director, 10%+ Owner
Signature
INNOVIVA, INC., by /s/ Pavel Raifeld, Chief Executive Officer
Stock symbol
ARMP
Transactions as of
Mar 31, 2022
Transactions value $
$26,926,040
Form type
4
Date filed
4/1/2022, 04:52 PM
Previous filing
Feb 23, 2022
Next filing
Jul 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARMP Common Stock Purchase $26.9M +5.39M +49.04% $5.00 16.4M Mar 31, 2022 See footnotes F1, F2
holding ARMP Common Stock 8.71M Mar 31, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARMP Warrants to Purchase Common Stock Purchase $0 0 0% $5.00 2.69M Mar 31, 2022 Common Stock 2.69M $5.00 See footnotes F1, F2
holding ARMP Warrants to Purchase Common Stock 1.81M Mar 31, 2022 Common Stock $5.00 See footnote F3
holding ARMP Warrants to Purchase Common Stock 6.15M Mar 31, 2022 Common Stock $3.25 See footnote F4
holding ARMP Warrants to Purchase Common Stock 8.71M Mar 31, 2022 Common Stock $2.87 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 See Exhibit 99.1
F2 See Exhibit 99.1
F3 See Exhibit 99.1
F4 See Exhibit 99.1
F5 See Exhibit 99.1